Check out a sample test report.
With KidneyIntelX™, you can more fully understand your patient’s risk for progressive decline in kidney function. Our highly-reliable, bioprognostic™ test yields a simple-to-understand, custom risk score, identifying adults with type 2 diabetes and with chronic kidney disease stages 1-3b who are at low, intermediate or high risk for progressive decline in kidney function.
In addition to the patient risk score, each test report comes complete with actionable, guideline‑recommended care pathways.
How can I best interpret the test results?
The KidneyIntelX risk score indicates the likelihood that your patient will experience rapid progressive decline in kidney function. There are three reported risk groups:
Low Risk Result
(5 to 45)
Approximately 50% of patients tested with KidneyIntelX are expected to receive a low-risk score. A low-risk score (“green”) means that your adult patient with type 2 diabetes and chronic kidney disease stages 1-3b, is at the lowest risk for progressive decline in kidney function. Clinical studies have shown that the risk that an individual with this score will experience such a decline over the next five years is < 10%.
Intermediate Risk Result
(50 to 85)
Approximately 35% of all patients tested with KidneyIntelX are expected to receive an intermediate risk score. With an intermediate-risk score (“orange”), you may recommend that the patient monitors his/her kidney health more frequently, which may include additional visits, additional blood work, some lifestyle changes and potentially, the introduction of specialized medication.
High Risk Result
(90 to 100)
Approximately 15% of patients tested with KidneyIntelX are expected to receive a high-risk score, which means that they have a 60% or higher chance of experiencing progressive decline in kidney function over the next five years. With a high-risk score, you may act more quickly and aggressively in the treatment of your patients’ kidney disease, which could include more frequent follow-up visits, referrals to a nephrologist, maximizing current medications and/or introducing new medications.
Is there ever a time when a result cannot be obtained?
At Renalytix Labs, we pride ourselves on optimizing utilization of each sample. In fact, our specimen processing error rate stands at less than 1%.
That said, a KidneyIntelX patient specimen will be rejected for any of the following reasons:
- Specimens where hemolysis or clotting is evident
- Specimens where less than 500uL of plasma is evident
- Specimens which are physically compromised in any way, including where breakage or leaking is evident
- Specimens received in syringes with needles attached
- Specimens with frozen whole blood
- Specimens with refrigerated (2º – 8º C) whole blood that is older than 8 days or refrigerated (2º – 8º C) plasma older than 14 days
- Specimens with ambient (9º – 26º C) whole blood that is older than 6 days or ambient (9º – 26º C) plasma older than 7 days
- Specimens received in an expired K2EDTA blood collection tube
Specimen Stability Guidelines Table
| Specimen Temperature | Specimen Type | Stability from time of collection |
|---|---|---|
| 2° – 8° C | K2EDTA Whole Blood | 8 days |
| 9° – 26° C | K2EDTA Whole Blood | 6 days |
| > 26° C | K2EDTA Whole Blood | Unacceptable |
| Frozen | K2EDTA Whole Blood | Unacceptable |
| 2° – 8° C | K2EDTA Plasma | 14 days |
| 9° – 26° C | K2EDTA Plasma | 7 days |
| > 26° C | K2EDTA Plasma | Unacceptable |
| Frozen | K2EDTA Plasma | 18 months at -60° to -90° C |
A UACR specimen will be rejected for any of the following reasons:
- Specimen of bloody urine
- Specimen of frozen urine
- Specimen of refrigerated urine that is older than 5 days
- Specimen of ambient urine that is older than 24 hours
Sample Stability and Acceptability
| Sample | Ambient | Refrigerated | Frozen |
|---|---|---|---|
| Urine | Day of collection | 5 days | Unacceptable |
| Blood, Plasma, Body Fluid | Unacceptable | Unacceptable | Unacceptable |
